HealthcareServices

DNA Sequencing Market to Grow at a CAGR of 16.5% from 2025 to 2029

November 24, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Future Market Size Estimation For The DNA Sequencing Market Covering 2025–2034?

The dna sequencing market has witnessed significant growth in recent years. Its value is projected to rise from $13.77 billion in 2024 to $15.8 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 14.7%. This past growth can be ascribed to several factors, including the human genome project, reductions in cost, the expansion of biomedical research, the adoption of clinical diagnostics, and the requirements of pharmaceutical R&D.

The dna sequencing market is anticipated to experience significant expansion in the coming years. This market is projected to reach $29.09 billion by 2029, achieving a compound annual growth rate (CAGR) of 16.5%. This expansion during the forecast period stems from factors such as next-generation sequencing (NGS) advancements, point-of-care sequencing, population genomics initiatives, the integration of AI and machine learning, and the increasing adoption of precision medicine. Key trends expected throughout this period encompass advancements in single-cell sequencing, a heightened focus on epigenetics and transcriptomics, the progression of liquid biopsy, considerations regarding ethics and privacy, and the incorporation of nanotechnology.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12604&type=smp

Which Factors And Drivers Are Influencing The DNA Sequencing Market In 2025?

The rising incidence of cancer is projected to drive the expansion of the DNA sequencing market moving forward. Cancer is defined as uncontrolled cellular proliferation, which affects various organs and contributes significantly to global morbidity and mortality. DNA sequencing plays a vital role in identifying genetic mutations, understanding tumor biology, and guiding treatment decisions, leading to improved outcomes in cancer care. For example, in January 2024, data from the American Cancer Society, a US-based nonprofit cancer advocacy organization, revealed that the number of cancer cases climbed to 2,001,140 compared to 1,958,310 in 2023, representing a growth of 2.19%. Thus, the growing prevalence of cancer is a primary impetus for the DNA sequencing market’s growth.

What Are The Major Segment Categories Driving The DNA Sequencing Market Growth?

The dna sequencingmarket covered in this report is segmented –

1) By Product: Instruments; Consumables; Services

2) By Technology: Third Generation DNA Sequencing; Next-Generation Sequencing; Sanger Sequencing

3) By Application: Diagnostics; Biomarkers And Cancer; Reproductive Health; Personalized Medicine; Forensics; Other Applications

4) By End User: Hospitals And Healthcare Organizations; Academics And Research Institutions; Pharmaceutical And Biotechnology Companies; Other End Users

Subsegments:

1) By Instruments: Next-Generation Sequencing (NGS) Systems; Sanger Sequencing Systems; Single-Molecule Sequencing Instruments

2) By Consumables: Reagents; Kits; Chips And Flow Cells

3) By Services: Sequencing Services; Data Analysis Services; Bioinformatics Services

What Key Innovation Trends Are Fueling Advancements In The DNA Sequencing Market?

Significant progress in single-cell DNA sequencing technologies represents a prominent trend increasingly adopted within the DNA sequencing market. Leading firms active in the DNA sequencing market are incorporating novel technologies to maintain their competitive standing. As an example, during May 2023, Mission Bio Inc., a US biotechnology company, introduced Tapestri v3, which is an enhanced iteration of their high-throughput single-cell DNA and multi-omics analysis platform. Tapestri v3 incorporates groundbreaking chemical enhancements, substantially improving the detection of rare cells across numerous applications. Thanks to its enhanced cell capture abilities, researchers can now identify minute quantities of single cells that were previously not detectable, allowing for a more profound comprehension of diseases. This advanced technology shows potential for uses like measurable residual disease (MRD) assessment in cancer, as Tapestri v3 facilitates the identification of relapse-driving clones that were previously overlooked. Furthermore, it provides advantages for developers of cell and gene therapies by allowing for quality evaluation at the individual cell level.

Who Are The Top Performing Companies In The DNA Sequencing Market In Recent Years?

Major companies operating in the DNA sequencing market include F. Hoffmann-La Roche Ltd, Abbott Laboratories Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Siemens Healthineers AG, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., BGI Genomics, Myriad Genetics Inc., Natera Inc., 10x Genomics Inc., GenScript Biotech Corporation, Novogene Corporation, Twist Bioscience, Genewiz LLC, Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Macrogen Inc., LI-COR Inc., MGI Tech Co. Ltd., Zymo Research Corporation, Igenomix, Codex DNA, GenapSys Inc., SeqOnce Biosciences Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/dna-sequencing-global-market-report

Which Region Is Projected To Lead The DNA Sequencing Market During The Forecast Period?

North America was the largest region in the DNA sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the DNA sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The DNA Sequencing Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12604&type=smp

Browse Through More Reports Similar to the Global DNA Sequencing Market 2025, By The Business Research Company

Dna Repair Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dna-repair-drugs-global-market-report

Dna And Gene Chip Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dna-and-gene-chip-global-market-report

Dna Based Skin Care Products Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dna-based-skin-care-products-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795